Robert Johnson
Amministratore Delegato presso Insmed Innovation UK Ltd.
Posizioni attive di Robert Johnson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Amministratore Delegato | 03/03/2022 | - |
Storia della carriera di Robert Johnson
Precedenti posizioni note di Robert Johnson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Fondatore | - | - |
Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Settori
Commercial Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Robert Johnson
- Esperienza